← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. Financial Ratios

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. Financial Ratios
  3. Quarterly

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. THC
  3. Financial Ratios
  4. Quarterly
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets

Tenet Healthcare Corporation (THC) Quarterly Financial Ratios

Last 48 quarters of trend data · Healthcare · Medical - Care Facilities

← View 30-Year Annual Ratios

Valuation Multiples

Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.

Tenet Healthcare Corporation's quarterly P/E stands at 5.9x, down 25.2% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has expanded 16.2% YoY to 6.0x, reflecting rising market expectations or slowing EBITDA growth.

MetricTTMQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
P/E Ratio →12.535.8911.7713.1514.017.879.518.5012.601.238.2117.5217.69
—-25.2%+23.9%+54.8%+11.2%+540.7%+15.7%-51.5%-28.8%-89.1%-38.0%+57.6%-52.9%
P/S Ratio0.800.770.790.850.770.610.600.780.640.490.370.340.42
—+25.9%+32.5%+8.5%+19.4%+24.2%+63.1%+130.9%+53.0%+57.0%+40.7%+15.0%+36.1%
P/B Ratio1.971.871.952.071.951.481.421.991.661.381.431.331.71
—+26.5%+37.5%+4.0%+16.9%+7.1%-0.9%+49.8%-2.4%+5.2%+26.9%+7.2%+22.6%
P/FCF6.722.8311.905.785.444.98—4.795.447.873.195.264.57
—-43.2%—+20.8%-0.1%-36.7%—-9.0%+18.9%+6.9%-67.7%-44.3%—
EV / EBITDA6.346.026.316.376.485.185.494.785.961.505.696.596.93
—+16.2%+15.0%+33.1%+8.7%+245.3%-3.6%-27.4%-14.0%-76.1%-12.2%+8.5%+9.6%
EV / EBIT7.947.597.997.687.875.926.495.537.311.597.259.129.45
—+28.2%+23.1%+39.0%+7.8%+272.9%-10.6%-39.4%-22.7%-81.5%-19.3%+12.3%-5.3%

Profitability

Quarterly margins and returns. Watch for margin compression across consecutive quarters.

Tenet Healthcare Corporation's operating margin was 16.4% in Q1 2026, up 0.7 pp QoQ and down 0.8 pp YoY. Gross margin contracted 80.1% YoY, suggesting cost inflation or competitive pricing pressure.

Margins

MetricTTMQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
Gross Margin82.3%16.4%15.7%58.3%82.3%82.6%40.3%39.5%39.7%39.4%39.6%37.5%37.5%
—-80.1%-61.0%+47.8%+107.4%+109.5%+1.8%+5.2%+5.9%+5.9%+8.5%+2.8%+2.3%
Operating Margin16.1%16.4%15.7%16.8%15.6%17.3%16.2%21.3%14.9%61.2%13.7%11.2%11.9%
—-4.8%-2.9%-20.9%+4.7%-71.8%+18.5%+89.6%+25.5%+409.6%+27.2%-9.7%-0.3%
Net Margin6.6%13.1%6.7%6.5%5.5%7.8%6.3%9.2%5.1%40.1%4.5%2.0%2.4%
—+68.2%+7.1%-29.8%+7.7%-80.6%+38.2%+362.2%+109.7%+1307.0%+121.9%-26.9%+195.4%

Return on Capital

MetricTTMQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
ROE16.1%7.9%4.2%4.0%3.4%4.7%3.8%5.9%3.3%32.6%4.6%2.0%2.5%
—+66.9%+9.7%-32.1%+1.9%-85.5%-16.2%+198.4%+32.9%+974.3%+105.5%-34.2%+181.4%
ROA4.8%2.3%1.3%1.2%1.0%1.4%1.1%1.6%0.9%7.5%0.9%0.4%0.5%
—+65.2%+15.1%-26.9%+11.6%-81.4%+24.9%+336.3%+96.3%+1325.3%+132.1%-24.4%+217.9%
ROIC13.2%3.4%3.4%3.5%3.3%3.6%3.5%4.7%3.2%13.2%2.9%2.2%2.4%
—-4.2%-1.4%-25.0%+3.1%-72.7%+20.8%+111.5%+34.1%+453.5%+33.0%-9.7%+1.9%

Leverage & Debt

Quarterly solvency trend — watch for debt spikes or covenant pressure.

Tenet Healthcare Corporation's Debt/EBITDA ratio is 11.9x — elevated, raising questions about debt serviceability. The current ratio has weakened 23.6% YoY to 1.36x, tightening the short-term liquidity position.

MetricTTMQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
Debt / Equity1.471.491.471.521.591.521.541.591.641.682.722.903.01
—-1.9%-4.8%-4.9%-3.0%-9.3%-43.4%-45.1%-45.6%-46.5%-16.8%-12.0%-17.9%
Debt / EBITDA3.0611.8911.9711.9112.7811.9012.999.9213.283.6915.7718.9918.42
—-0.1%-7.8%+20.1%-3.8%+222.7%-17.6%-47.8%-27.9%-80.0%-21.6%+1.3%-6.0%
Current Ratio1.761.361.761.711.711.781.781.581.451.441.511.431.44
—-23.6%-1.3%+8.3%+18.0%+23.1%+18.4%+10.2%+0.3%+3.8%+12.7%+2.3%+4.0%
Quick Ratio1.681.301.681.641.631.701.701.521.381.371.421.341.35
—-23.4%-1.3%+7.9%+18.2%+24.0%+19.9%+13.1%+2.4%+5.9%+13.9%+2.4%+3.6%
Interest Coverage4.414.304.244.464.124.754.235.563.8915.153.292.522.65
—————————————

Download Financial Ratios Data

Includes 30+ ratios · 48 years · Updated daily

Full THC Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

See THC's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is THC Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare with Peers

Compare business quality, growth, and profitability against top sector peers.

Start Comparison

THC — Frequently Asked Questions

Quick answers to the most common questions about buying THC stock.

What is Tenet Healthcare Corporation's quarterly P/E ratio trend?

Tenet Healthcare Corporation's current P/E is 12.5x. The average P/E over the last 4 quarters is 11.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.

How do Tenet Healthcare Corporation's margins change by quarter?

Tenet Healthcare Corporation's current operating margin is 16.1%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.

Why look at THC quarterly ratios instead of annual?

Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Tenet Healthcare Corporation's business trajectory between earnings reports.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.